NNP
AGN

Nachman Norwood & Parrott’s Allergan plc AGN Stock Holding History

Nachman Norwood & Parrott’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,667
Closed -$827K – 244
2020
Q1 		$827K Buy
4,667
+181
+4% +$34.1K 0.17% 94
2019
Q4 		$858K Hold
4,486
– – 0.14% 115
2019
Q3 		$755K Hold
4,486
– – 0.13% 121
2019
Q2 		$751K Sell
4,486
-21
-0.5% -$2.91K 0.14% 119
2019
Q1 		$660K Buy
4,507
+91
+2% +$13.2K 0.12% 128
2018
Q4 		$590K Buy
+4,416
New +$724K 0.12% 125

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Nachman Norwood & Parrott's AGN Position: Q2 2020 in Review

Nachman Norwood & Parrott sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,667 shares — an estimated $827K sold.

Nachman Norwood & Parrott first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $858K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Nachman Norwood & Parrott reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Nachman Norwood & Parrott sold 4,667 Allergan plc shares in Q2 2020, an estimated $827K.
  • Nachman Norwood & Parrott first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Nachman Norwood & Parrott's Allergan plc position peaked at $858K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q2 2020, filed 16 Jul 2020.